Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 24 April 2024
Accepted: 24 September 2024
First Online: 7 October 2024
Declarations
:
: Not applicable.
: Not applicable.
: AD has received research grants from Novartis and Eli Lilly and consulting fees from AbbVie, Amgen, Janssen, and Novartis. MM has received research grants from AbbVie, Amgen, BMS, and UCB and has received consulting fees from Eli Lilly, UCB, Pfizer, Janssen, AbbVie, and Novartis. AD has received research grants from AbbVie, Bristol Myers Squibb, Celgene, Eli Lilly, Galvani, Janssen, MoonLake, Novartis, Pfizer, and UCB and has received consulting fees from AbbVie, Aurinia, Bristol Myers Squibb, Eli Lilly, Janssen, MoonLake, Novartis, Pfizer, and UCB.
